Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
UP Catalyst develops and manufactures sustainable carbon nanomaterials—including multi-walled carbon nanotubes, carbon black, hard carbon, and graphite—using proprietary processes that convert industrial CO₂ emissions or waste biomass into high-value products. Their technology offers dramatically lower environmental impact compared to conventional methods. The company has raised significant funding to build large-scale production facilities in Europe. No clinical results as the company does not operate in life sciences or healthcare.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on UP Catalyst.